Human gene therapy: a biopolitical overview and analysis.

The benefits, risks, and social consequences arising from human gene therapy have received substantial citation in the literatures of medical, biological, ethical, and legal commentary. I argue that the question of what "public policy garb" best fits the parameters of human gene therapy in the United States and around the world is a quintessential political question, best understood under the microscope of political science analytic inquiry. I describe the nature of that inquiry, apply its insights to the various ends and means of human gene therapy, and posit empirical models of "political success" for the salient purposes of the craft. I focus particularly on the tract record of the National Institutes of Health's Recombinant DNA Advisory Committee (RAC) in orchestrating the process by which human gene therapy protocols achieve official sanction.

[1]  C. Holden.  Crime conference. Back to the drawing board, says NIH. , 1992, Science.

[2]  R. Stone.  NIH to size up growth hormone trials. , 1992, Science.

[3]  B. Davis.  Germ-line therapy: evolutionary and moral considerations. , 1992, Human gene therapy.

[4]  D. Koshland.  Fetal tissue research. , 1992, Science.

[5]  W. Anderson,et al.  Germ-Line Gene Therapy: A New Stage of Debate , 1992, Law, medicine & health care : a publication of the American Society of Law & Medicine.

[6]  E. Juengst.  The NIH "Points to Consider" and the limits of human gene therapy. , 1990, Human gene therapy.

[7]  A. Vidaver,et al.  Risk-based oversight of experiments in the environment , 1990, Science.

[8]  R. Cook-Deegan.  Human gene therapy and congress. , 1990, Human gene therapy.

[9]  I. H. Carmen.  Chess algorithms of supreme court decision making: A bioconstitutional politics analysis , 1989 .

[10]  B. Guy Peters,et al.  Policy Paradox and Political Reason , 1988, American Political Science Review.

[11]  I. H. Carmen.  Bioconstitutional Politics: Toward an Interdisciplinary Paradigm , 1987, Politics and the Life Sciences.

[12]  I. H. Carmen.  The Constitution in The Laboratory: Recombinant DNA Research as "Free Expression" , 1981, The Journal of Politics.

[13]  D. Hartl,et al.  The Political Implications of Human Genetic Technology , 1981 .

[14]  L Walters,et al.  Human gene therapy: ethics and public policy. , 1991, Human gene therapy.

[15]  S. Krimsky.  Human gene therapy: must we know where to stop before we start? , 1990, Human gene therapy.

[16]  T. Murray.  Human gene therapy, the public, and public policy. , 1990, Human gene therapy.

[17]  H. Miller.  Human gene therapy: part of a therapeutic continuum. , 1990, Human gene therapy.

[18]  J. Areen,et al.  Legal regulation of human gene therapy. , 1990, Human gene therapy.

[19]  A. Capron.  The impact of the report, Splicing Life. , 1990, Human gene therapy.